Approved for Prevention of invasive disease caused by Neisseria meningitidis serogroup B. Trumenba contains two recombinant lipidated factor H binding protein (fHBP) variants from Neisseria meningitidis serogroup B. These antigens stimulate the production of bactericidal antibodies that… Side effects, costs, interactions, manufacturer, and generic alternatives sourced from FDA labels, openFDA…
Loading full data from Know Your Drugs Institute…